Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Urothelial Carcinoma​

Quantifying MICs Included in the CPS Numerator- Challenging Scenarios

In this advanced PD-L1 IHC 22C3 pharmDx Tutorial Video, you will learn to:

  • Recognize scenarios that can make it challenging to accurately quantify tumor-associated PD-L1 staining MICs to include in the Combined Positive Score (CPS) numerator
  • Determine whether PD-L1 staining immune cells are tumor-associated MICs that should be included in the CPS numerator
  • Easily exclude non-MIC immune cell staining and other cell staining from the CPS numerator

 

Agilent’s PD-L1 IHC 22C3 pharmDx tutorial videos are an engaging and convenient resource for advancing your knowledge of PD-L1 interpretation using Tumor Proportion Score (TPS) and CPS. Through these trainings we will help you to confidently:​

  • Understand the fundamentals of TPS and CPS including key inclusion and exclusion criteria for evaluation​
  • Navigate challenging morphology and staining characteristics​
  • Apply helpful strategies to confidently determine PD-L1 expression levels using TPS and CPS​

Related Training

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.D0125524_1.00